The presence of transthyretin cardiac amyloidosis in patients undergoing coronary artery bypass graft surgery

Highlights

• This is the first published study specifically targeting cardiac amyloidosis screening in patients presenting with coronary artery disease.
• Screening for cardiac amyloidosis at the time of coronary artery bypass surgery did not yield any new diagnosis.
• No adverse events were associated with myocardial biopsy at the time of cannulation for cardiac bypass.